Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-25-017426
Filing Date
2025-05-16
Accepted
2025-05-16 16:29:58
Documents
21
Period of Report
2025-05-12
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A omer20250515_8ka.htm   iXBRL 8-K/A 25288
2 EXHIBIT 4.2 ex_819409.htm EX-4.2 782783
7 convrate2.jpg GRAPHIC 5183
8 convrate3.jpg GRAPHIC 5228
9 convrate4.jpg GRAPHIC 5101
10 convrate5.jpg GRAPHIC 4451
11 convrate6.jpg GRAPHIC 7110
12 convrate.jpg GRAPHIC 4671
  Complete submission text file 0001437749-25-017426.txt   1107976

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA omer-20250512.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omer-20250512_def.xml EX-101.DEF 11792
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE omer-20250512_lab.xml EX-101.LAB 15821
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omer-20250512_pre.xml EX-101.PRE 12007
23 EXTRACTED XBRL INSTANCE DOCUMENT omer20250515_8ka_htm.xml XML 2985
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

EIN.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-34475 | Film No.: 25959732
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)